Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels.
Sign Up to like & getrecommendations! Published in 2018 at "Contributions to nephrology"
DOI: 10.1159/000485696
Abstract: Fibroblast growth factor 23 (FGF23) is a regulator of phosphate and vitamin D homeostasis that carries out primary bone- and mineral-related physiological functions to increase renal phosphate excretion and reduce 1α-hydroxylation of 25-hydroxyvitamin D. In… read more here.
Keywords: serum fgf23; hemodialysis; hemodialysis patients; phosphate calcium ... See more keywords